<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
<channel>
<title>Latest Biology Technology from Bio-Medicine.Org</title>
<link>http://www.bio-medicine.org/biology-technology-1/</link>
<description>Latest Biology Technology lists</description>
<language>en-us</language>
<copyright>Copyright 2007. Bio-Medicine All Rights Reserved.</copyright>
<item>
<title><![CDATA[ImaRx Postpones Release of First Quarter 2008 Financial Results]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/ImaRx-Postpones-Release-of-First-Quarter-2008-Financial-Results-5369-1/</link>
<pubDate>Tue, 13 May 2008 02:16:32 MST</pubDate>
<description><![CDATA[Live Webcast and Conference Call Scheduled for Thursday, May 15th at 5 PM                                   ET   TUCSON, Ariz., May 13 /- ImaRx Therapeutics, Inc. (Nasdaq:  IMRX ) today announced that the Company has postponed its live webcast and conference call to Thursday, May 15, 2008, at 5:00 p.m. ET to discuss first quarter 2008 financial results; this call was orig... ]]></description>
</item>
<item>
<title><![CDATA[Chindex International Announces Shelf Registration, Related Strategy and Guidance]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Chindex-International-Announces-Shelf-Registration--Related-Strategy-and-Guidance-5368-1/</link>
<pubDate>Tue, 13 May 2008 02:16:20 MST</pubDate>
<description><![CDATA[BETHESDA, Md., May 13 /Xinhua-- Chindex International, Inc. (Nasdaq:  CHDX ), a leading independent American provider of Western healthcare services and products in the People's Republic of China, announced that it has filed a shelf registration statement with the Securities and Exchange Commission (SEC) that, if declared effective by the SEC, would allow the Company to sell, fr... ]]></description>
</item>
<item>
<title><![CDATA[PharmAthene Reports First Quarter 2008 Financial Results]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/PharmAthene-Reports-First-Quarter-2008-Financial-Results-5367-1/</link>
<pubDate>Tue, 13 May 2008 01:23:44 MST</pubDate>
<description><![CDATA[ANNAPOLIS, Md., May 13 /- PharmAthene, Inc. (Amex:  PIP ) a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial results for the first quarter ended March 31, 2008.   "The first quarter was a particularly productive and exciting time for our Company. With the acquisition of Avecia's biodefense vaccines... ]]></description>
</item>
<item>
<title><![CDATA[Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Interleukin-Genetics-to-Present-at-Rodman--26-Renshaw-5th-Annual-Global-Healthcare-Conference-5366-1/</link>
<pubDate>Tue, 13 May 2008 01:23:29 MST</pubDate>
<description><![CDATA[WALTHAM, Mass., May 13 /- Interleukin Genetics, Inc. (Amex:  ILI ) announced today that Lewis H. Bender, Chief Executive Officer, will present at the Rodman and Renshaw 5th Annual Global Healthcare Conference on Monday May 19, 2008, at 10:00 a.m. CEST (4:00 a.m. EDT). The conference will be held at Le Meridien Beach Plaza Hotel, Monte Carlo, Monaco.   A live audio webc... ]]></description>
</item>
<item>
<title><![CDATA[Amicus Therapeutics Announces First Quarter 2008 Financial Results]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Amicus-Therapeutics-Announces-First-Quarter-2008-Financial-Results-5365-1/</link>
<pubDate>Tue, 13 May 2008 01:23:14 MST</pubDate>
<description><![CDATA[Strong financial position supports clinical focus on advancing drug        candidates for treatment of lysosomal storage disorders   CRANBURY, N.J., May 13 /- Amicus Therapeutics (Nasdaq:  FOLD ), a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment of human genetic diseases, today announced financial r... ]]></description>
</item>
<item>
<title><![CDATA[Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Chindex-International-Announces-Conference-Call-to-Discuss-Its-Fiscal-2008-Fourth-Quarter-and-Year-End-Results-on-Thursday--June-12--2008-5364-1/</link>
<pubDate>Tue, 13 May 2008 01:22:56 MST</pubDate>
<description><![CDATA[BETHESDA, Md., May 13 /Xinhua-- Chindex International, Inc. (Nasdaq:  CHDX ) a leading independent American provider of Western healthcare products and services in the People's Republic of China, announced that it intends to release its financial results for the fourth quarter ended March 31, 2008, on Thursday, June 12, 2008.   Chindex's management will also host a conference ca... ]]></description>
</item>
<item>
<title><![CDATA[Particle Sciences Adds Additional Clean Room Space]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Particle-Sciences-Adds-Additional-Clean-Room-Space-5363-1/</link>
<pubDate>Tue, 13 May 2008 01:22:44 MST</pubDate>
<description><![CDATA[BETHLEHEM, Pa., May 13 /- Particle Sciences has expanded its production capacity by the addition of a 500 sq ft Class 1000 (ISO 6) clean room. The space also contains several Class 100 hoods for sterile work. The space was added to the existing 15,000 sq ft facility in response to the increasing need for clinical trial material manufacturing, especially that of semisolids, suspe... ]]></description>
</item>
<item>
<title><![CDATA[Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Jazz-Pharmaceuticals--Inc--Announces-First-Quarter-2008-Financial-Results-5362-1/</link>
<pubDate>Tue, 13 May 2008 01:22:28 MST</pubDate>
<description><![CDATA[- LUVOX(R) CR Approved and Launched   - Screening Closed in First Phase III Fibromyalgia Clinical Trial   PALO ALTO, Calif., May 13 /- Jazz Pharmaceuticals, Inc. (Nasdaq:  JAZZ ) today announced financial results for the quarter ended March 31, 2008.   Total revenues for the quarter ended March 31, 2008 were $14.6 million, compared to $14.1 million for... ]]></description>
</item>
<item>
<title><![CDATA[Sigma-Aldrich Recognized by BioInformatics, LLC as Having the Most Useful and Easiest to Use Online and Print Catalogs]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Sigma-Aldrich-Recognized-by-BioInformatics--LLC-as-Having-the-Most-Useful-and-Easiest-to-Use-Online-and-Print-Catalogs-5361-1/</link>
<pubDate>Tue, 13 May 2008 01:22:10 MST</pubDate>
<description><![CDATA[Catalog serves as definitive source for life science researchers   ST. LOUIS, May 13 /- Sigma-Aldrich (Nasdaq: SIAL) is pleased to announce that BioInformatics, LLC, a leading market research company for the life science industry, reports that the Company's online product catalog ( http://www.sigma-aldrich.com/catalog ) is considered by scientists to be "most useful"... ]]></description>
</item>
<item>
<title><![CDATA[Insulet Reports First Quarter 2008 Results]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Insulet-Reports-First-Quarter-2008-Results-5360-1/</link>
<pubDate>Tue, 13 May 2008 01:21:57 MST</pubDate>
<description><![CDATA[1,200 New Patients Shipped in the Quarter           Production Increases to 95,000 OmniPods per Month               Salesforce Expands to Cover All 50 States   BEDFORD, Mass., May 13 /- Insulet Corporation (Nasdaq:  PODD ), a leader in wearable insulin pump technology with its OmniPod(R) Insulin Management System, today announced financial results for the... ]]></description>
</item>
<item>
<title><![CDATA[Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Lilly-Backs-Federal-Legislation-to-Inform-the-Public-on-Payments-to-Physicians-5359-1/</link>
<pubDate>Tue, 13 May 2008 12:15:11 MST</pubDate>
<description><![CDATA[Support for Grassley-Kohl Bill Newest Addition to Lilly's 'Transparency                                Agenda'   INDIANAPOLIS, May 13 /- Today Eli Lilly and Company (NYSE:  LLY ) announced its support of the newly revised Physicians Payments Sunshine Act, sponsored by United States Senators Charles Grassley (R-Iowa) and Herbert Kohl (D-Wisconsin). The bipartisan bill wou... ]]></description>
</item>
<item>
<title><![CDATA[Serving Those Who Serve Our Country: Medical Device Company Answers the Call of a U.S. Combat Hospital in Iraq]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Serving-Those-Who-Serve-Our-Country-3A-Medical-Device-Company-Answers-the-Call-of-a-U-S--Combat-Hospital-in-Iraq-5358-1/</link>
<pubDate>Tue, 13 May 2008 11:18:28 MST</pubDate>
<description><![CDATA[NASHUA, N.H., May 13 /- When Sergeant Heather Maddy of the 325th Combat Support Hospital in Iraq e-mailed Vascular Technology, Incorporated (VTI) of Nashua, NH inquiring about a desperately needed piece of critical care equipment called a Surgical Doppler for her operating rooms, she never expected one to be delivered within days -- free of charge.   "I would like to let you kno... ]]></description>
</item>
<item>
<title><![CDATA[New York Benefit to Celebrate Recent Medical Marijuana Successes]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/New-York-Benefit-to-Celebrate-Recent-Medical-Marijuana-Successes-5357-1/</link>
<pubDate>Tue, 13 May 2008 11:18:16 MST</pubDate>
<description><![CDATA[A Night of Music & Comedy to Help Push Campaign to Victory May 14, 2008 -                           Highline Ballroom  Spring Soiree to Benefit Effort to Protect Seriously Ill New York Patients                       Who Use Medical Marijuana   NEW YORK, May 13 /- The Marijuana Policy Project (MPP.org) will host a spring soiree, a night of comedy and music to benefit MPP's efforts t... ]]></description>
</item>
<item>
<title><![CDATA[Hospira Expands Board of Directors]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Hospira-Expands-Board-of-Directors-5356-1/</link>
<pubDate>Tue, 13 May 2008 11:18:04 MST</pubDate>
<description><![CDATA[LAKE FOREST, Ill., May 13 /- Hospira, Inc. (NYSE:  HSP ), a global specialty pharmaceutical and medication delivery company, announced today that Barbara L. Bowles, CFA, has been elected to the company's board of directors. Bowles brings strong investment management and finance expertise from leadership positions held at major multinational consumer goods companies and... ]]></description>
</item>
<item>
<title><![CDATA[Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd.]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Kiwa-Bio-Tech-Confirms-Joint-Venture-Agreement-With-Shijiazhuang-Huaxing-Animal-Medicine-Co---Ltd--5355-1/</link>
<pubDate>Tue, 13 May 2008 10:14:15 MST</pubDate>
<description><![CDATA[BEIJING and CLAREMONT, Calif., May 13 /Xinhua-- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) announced finalization of an agreement establishing a joint venture company capable of producing Kiwa's AF-01 anti-viral product.   On May 9, General Manager of Shijiazhuang Huaxing Animal Medicine Co., Ltd. (''Huaxing''), Mr. Ruijun Li and his associates... ]]></description>
</item>
<item>
<title><![CDATA[China Sky One Medical, Inc. Announces Record First Quarter 2008 Results]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/China-Sky-One-Medical--Inc--Announces-Record-First-Quarter-2008-Results-5354-1/</link>
<pubDate>Tue, 13 May 2008 10:14:01 MST</pubDate>
<description><![CDATA[HARBIN, China, May 13 /Xinhua-- China Sky One Medical, Inc. (OTC Bulletin Board: CSKI) ("China Sky One" or "the Company"), a China based developer, manufacturer, marketer and international distributor of pharmaceutical, medicinal and diagnostic products, today announced record financial results for the first quarter ended March 31, 2008.     First Quarter 2008 Highligh... ]]></description>
</item>
<item>
<title><![CDATA[ThromboGenics N.V. - Business Update]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/ThromboGenics-N-V----Business-Update-5353-1/</link>
<pubDate>Tue, 13 May 2008 09:17:08 MST</pubDate>
<description><![CDATA[LEUVEN, Belgium, May 13 /-   - Regulated Information   ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on innovative treatments for vascular disease, eye disease and cancer, is today issuing a business update for the three month period ended 31 March 2008.   Prof. Desire Collen, CEO and Chairman of ThromboGenics, commenting on today's announc... ]]></description>
</item>
<item>
<title><![CDATA[Angiotech appoints Hank McKinnell to its Board of Directors]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Angiotech-appoints-Hank-McKinnell-to-its-Board-of-Directors-5352-1/</link>
<pubDate>Tue, 13 May 2008 09:16:56 MST</pubDate>
<description><![CDATA[VANCOUVER, May 13 / Angiotech Pharmaceuticals, Inc. (NASDAQ:  ANPI , TSX: ANP), a global specialty pharmaceutical and medical device company, today announced the appointment of Dr. Hank McKinnell to its Board of Directors.   Dr. McKinnell is the former Chief Executive Officer and former Chairman of the Board of Directors of Pfizer Inc. He is currently Chairman of the A... ]]></description>
</item>
<item>
<title><![CDATA[Biodel Inc. Added to NASDAQ Biotechnology Index]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/Biodel-Inc--Added-to-NASDAQ-Biotechnology-Index-5351-1/</link>
<pubDate>Tue, 13 May 2008 08:13:11 MST</pubDate>
<description><![CDATA[DANBURY, Conn., May 13 /- Biodel Inc. (Nasdaq: BIOD) today announced that the Company has been selected for inclusion in the NASDAQ Biotechnology Index (NBI), effective as of the market's open on Monday, May 19, 2008.   "We are pleased to be included in the NASDAQ Biotechnology Index and believe Biodel's inclusion is a result of the Company's consistent achievement of... ]]></description>
</item>
<item>
<title><![CDATA[ViroPharma to Present at the Seventh Annual JMP Securities Research Conference]]></title>
<link>http://www.bio-medicine.org/biology-technology-1/ViroPharma-to-Present-at-the-Seventh-Annual-JMP-Securities-Research-Conference-5350-1/</link>
<pubDate>Tue, 13 May 2008 08:13:00 MST</pubDate>
<description><![CDATA[EXTON, Pa., May 13 /- ViroPharma Incorporated (Nasdaq:  VPHM ) today announced that Vincent Milano, president and chief executive officer of ViroPharma, will present at the Seventh Annual JMP Securities Research Conference at 5:00 P.M. ET on Monday, May 19, 2008. The conference is being held at the Ritz-Carlton San Francisco.   ViroPharma's presentation will be webcast... ]]></description>
</item>
</channel>
</rss>